Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features
Abstract
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML), classified by a translocation between chromosomes 15 and 17 [t(15;17)], that is considered a true oncologic emergency though appropriate therapy is considered curative. Therapy is often initiated on clinical suspicion, informed by both clinical presentation as well as direct visualization of the peripheral smear. We hypothesized that genomic imprinting of morphologic features learned by deep learning pattern recognition would have greater discriminatory power and consistency compared to humans, thereby facilitating identification of t(15;17) positive APL. By applying both cell-level and patient-level classification linked to t(15;17) PML/RARA ground-truth, we demonstrate that deep learning is capable of distinguishing APL in both discovery and prospective independent cohort of patients. Furthermore, we extract learned information from the trained network to identify previously undescribed morphological features of APL. The deep learning method we describe herein potentially allows a rapid, explainable, and accurate physician-aid for diagnosing APL at the time of presentation in any resource-poor or -rich medical setting given the universally available peripheral smear.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 14, 2021
- Source ID
- 10.1038/s41698-021-00179-y
Entities
People
- Adam Luo
- Alexander S Baras
- Alison R Moliterno
- Amy E. Dezern
- Amy S. Duffield
- Bo-shiun Lai
- Bryan C Hambley
- Christian B. Gocke
- Eugene Shenderov
- Ingharan J. Siddarthan
- Jennifer Bynum
- John-William Sidhom
- Lukasz P. Gondek
- Mark J. Levis
- Michael B. Streiff
- Philip Imus
- Thomas Kickler
Organizations
- Prostate Cancer Foundation
- United States Department of Defense